Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (12) , 1965-1967
- https://doi.org/10.1016/0959-8049(92)90238-w
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A phase II study of high dose epirubicin in unresectable non small cell lung cancerBritish Journal of Cancer, 1992
- Activity of high-dose epirubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Phase II study of high-dose epirubicin in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Role of systemic therapy in advanced non-small-cell lung cancerThe American Journal of Medicine, 1990
- Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.Journal of Clinical Oncology, 1990
- A New International Staging System for Lung CancerChest, 1986
- Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the futureCancer Treatment Reviews, 1983